Altogether, the current evidence shows that Ng is a promising biomarker reflecting early synaptic dysfunction in AD, which can have a predictive value in healthy controls as well as MCI patients, in a surprisingly AD-specific manner. Here, NRGN is linked to Alzheimer disease.